clinical trial
Canhelp Genomics Partners With Mirxes Singapore to Offer Tumor Origin Identification Testing
The firms will make the Canhelp-Origin tumor identification test available for patients with cancers of unknown origin in some Southeast Asian countries.
Sysmex Inostics Gets NYS CLEP Approval for Clinical Trial Use of Liquid Biopsy Assay
The Baltimore-based subsidiary of Japan's Sysmex said that the test is used to identify genetic mutations that are relevant for the treatment of various cancer types.
Exact Sciences Enrolls First Patient in Multi-Cancer Early Detection Study
Participants enrolled in the registry study will receive three years of MCED testing and two years of follow-on data collection.
BMJ Report Reveals UK Officials' Concerns Over Grail Test Effectiveness, Trial Design
The report also mentions a US investor class action lawsuit that alleges Illumina and Grail officials oversold Galleri's potential.
Thermo Fisher, NCI Partner for Myeloid Cancer Precision Medicine Umbrella Trial
For the MyeloMATCH trial, researchers will use the Ion Torrent Genexus sequencer to test bone marrow and blood samples and match patients with appropriate treatments.